OM DENNA PODDSÄNDNING 🔗

Genomsnittlig ljudlängd:
6 minutes
Engelsk
USA
10 avsnitt
sedan 12 november 2015
episodic

SENASTE AVSNITTET 🔗

Dr Hong talks to ecancertv at ASTRO 2015 about a prospective, open-label phase II, study of proton-based stereotactic body radiotherapy (SBRT) in patients with liver metastases. The study findings showed that proton SBRT was associated with high rates of local control and that there was a favourab…

SÖK TIDIGARE AVSNITT

Sök efter tidigare avsnitt från ASTRO 2015.

TIDIGARE AVSNITT

Dr Hoyer talks to ecancertv at ASTRO 2015 about his lecture during the ASTRO/ESTRO Joint Session 'Novel treatment approaches for oligometastases'. In the interview he provides background on how oligometastases have been managed in the past and how stereotactic body radiation therapy (SBRT) is bein…
Dr Hong talks to ecancertv about one of the nursing sessions held at ASTRO 2015 that looked at the care of patients receiving chemoradiation. In the interview he outlines that the aims of the session were to provide an overview of the data and rationale for why certain chemoradiation strategies we…
Dr Abazeed talks to ecancertv at ASTRO 2015 about research being conducted at the Cleveland Clinic looking at whether it is possible to use genomic parameters to predict how tumours will respond to radiation therapy. In the interview he highlights that there is an underlying genetic diversity of c…
Mr DiGiaimo talks to ecancertv at ASTRO 2015 about some of his research highlights and the potential economic considerations of using newer radiation technologies over conventional standards.
Dr Haffty talks to ecancertv at ASTRO 2015 about some of the research highlights of the meeting including the Presidential Symposium, which looks at the role of radiation therapy in the multidisciplinary management of gastrointestinal malignancies. In the interview he also outlines some of the rec…
Dr Kavanagh, President-elect to the ASTRO board of directors, talks to ecancertv about the theme of ASTRO 2015 – Technology Meets Patient Care – and how the research and presentations being given relate to this. In the interview he highlights research that is not only comparing the effectiveness o…
Dr Palma talks to ecancertv at ASTRO 2015 about the concept of oligometastases and how novel approaches such as stereotactic radiation therapy may be used to treat patients with multiple metastases. In the interview he notes that better evidence is needed to determine which patients may benefit fr…
Dr Chang talks to ecancertv at ASTRO 2015 about the use of stereotactic body radiation therapy (SBRT) in non-small cell lung cancer (NSCLC) and whether it can be used in patients with early disease that is still operable. He explains that SBRT is being used in early NSLC but that this is usually i…
Dr Palma talks to ecancertv at ASTRO 2015 about a session on using stereotactic radiation therapy for early-stage nonsmall-cell lung cancer (NSCLC). During the session talks were given on using the method for operable stage 1 NSCLC and on the risk for recurrence following stereotactic radiation th…
Ansvarsfriskrivning: Podcasten och konstverket som är inbäddat på den här sidan är från ecancer.org, som är dess ägares egendom och inte anslutet till eller godkänt av Listen Notes, Inc.